Montelukast - Bristol Laboratories Ltd
Bristol Laboratories
Description
A leukotriene receptor antagonist that inhibits bronchoconstriction by blocking the inflammatory response in the airways.
Prophylaxis of asthma
• Child 6 months–5 years: 4 mg once daily in the evening.
• 6–14 years: 5 mg once daily in the evening.
• Adult and child over 15 years: 10 mg once daily in the evening.
Seasonal allergic rhinitis in patients with asthma
• Adult and child over 15 years: 10 mg once daily in the evening.
Indications
For use in the management of exercise induced asthma and symptomatic relief of seasonal allergic rhinitis in patients with asthma.
Contraindications
Manufacturer advises to avoid in pregnancy and when breast feeding, unless essential.
Preparations Available
Tablets, Chewable tablets
Sizes Available
Tablets
10 mg, 28-tab pack
Chewable tablets
4 mg, sugar free, 28-tab pack
5 mg, sugar free, 28-tab pack
More on: Leukotriene receptor antagonists , Montelukast